Mass production of soluble human MHC class II molecules by CD74 co-expression

hPSC-based Regenerative Medicine by Innovative Technology Completely Overcoming Tumorigenicity

Platform technology with high through put design and development of tumorigenic cell-targeting lentiviral vector (TC-LV), and producing master cells

Cell based therapy for vascular regeneration

Vascular endothelial stem cells (VESCs) based therapy is a promising approach for vascular regeneration.